UA79443C2 - Use of anastrozole for treating post-menopausal woman having early breast cancer - Google Patents

Use of anastrozole for treating post-menopausal woman having early breast cancer Download PDF

Info

Publication number
UA79443C2
UA79443C2 UA20040705521A UA20040705521A UA79443C2 UA 79443 C2 UA79443 C2 UA 79443C2 UA 20040705521 A UA20040705521 A UA 20040705521A UA 20040705521 A UA20040705521 A UA 20040705521A UA 79443 C2 UA79443 C2 UA 79443C2
Authority
UA
Ukraine
Prior art keywords
anastrozole
tamoxifen
breast cancer
patients
treatment
Prior art date
Application number
UA20040705521A
Other languages
English (en)
Ukrainian (uk)
Inventor
Paul Plourde
Anthony Rogers
Brent Vose
Michael Dukes
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9927290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA79443(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UA79443C2 publication Critical patent/UA79443C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical Treatment Of Metals (AREA)
UA20040705521A 2001-12-10 2002-06-12 Use of anastrozole for treating post-menopausal woman having early breast cancer UA79443C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0129457.8A GB0129457D0 (en) 2001-12-10 2001-12-10 Method of treatment
PCT/GB2002/005554 WO2003053438A1 (en) 2001-12-10 2002-12-06 Use of anastrozole for the treatment of post-menopausal women having early breast cancer

Publications (1)

Publication Number Publication Date
UA79443C2 true UA79443C2 (en) 2007-06-25

Family

ID=9927290

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20040705521A UA79443C2 (en) 2001-12-10 2002-06-12 Use of anastrozole for treating post-menopausal woman having early breast cancer

Country Status (28)

Country Link
US (1) US20050165081A1 (de)
EP (2) EP1997492A1 (de)
JP (2) JP5335173B2 (de)
KR (1) KR100858946B1 (de)
CN (1) CN100408036C (de)
AT (1) ATE406160T1 (de)
AU (1) AU2002347371B2 (de)
BR (1) BR0214798A (de)
CA (1) CA2468965C (de)
CO (1) CO5590926A2 (de)
CY (1) CY1108462T1 (de)
DE (1) DE60228616D1 (de)
DK (1) DK1455781T3 (de)
ES (1) ES2303811T3 (de)
GB (1) GB0129457D0 (de)
HU (1) HUP0402023A3 (de)
IL (1) IL162150A0 (de)
IS (1) IS7300A (de)
MX (1) MXPA04005394A (de)
NO (1) NO20042912L (de)
NZ (1) NZ533106A (de)
PL (1) PL369411A1 (de)
PT (1) PT1455781E (de)
RU (1) RU2320339C2 (de)
SI (1) SI1455781T1 (de)
UA (1) UA79443C2 (de)
WO (1) WO2003053438A1 (de)
ZA (1) ZA200404260B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0129457D0 (en) * 2001-12-10 2002-01-30 Astrazeneca Ab Method of treatment
US8436029B2 (en) * 2004-03-19 2013-05-07 Transform Pharmaceuticals, Inc. Pharmaceutical forms, and methods of making and using the same
WO2005117864A1 (en) * 2004-05-28 2005-12-15 Astrazeneca Ab Combination product comprising anastrozole and a dual prenyl transferase inhibitor
CN100337625C (zh) * 2004-08-30 2007-09-19 鲁南制药集团股份有限公司 阿那曲唑的分散片剂型
CN1304054C (zh) * 2004-12-29 2007-03-14 山东蓝金生物工程有限公司 一种缓慢释放的抗癌药物组合物
GB0517673D0 (en) * 2005-08-31 2005-10-05 Astrazeneca Ab Formulation
GB0517674D0 (en) * 2005-08-31 2005-10-05 Astrazeneca Ab Formulation
WO2011130381A1 (en) * 2010-04-13 2011-10-20 Estrocept Diagnostics, Inc. Diagnostic assays for breast cancer treatment and progression
US10201549B2 (en) 2013-06-14 2019-02-12 Professional Compounding Centers Of America (Pcca) Testosterone combined with anastrozole injection solutions
CN103450099B (zh) * 2013-09-06 2015-03-25 杭州华东医药集团新药研究院有限公司 阿那曲唑及其一水合物的新晶型、制备和用途
RU2548722C1 (ru) * 2013-12-06 2015-04-20 Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" Противоопухолевое лекарственное средство пролонгированного действия на основе противоопухолевого препарата, ингибитора синтеза эстрогенов - анастрозола
DE102014005513B4 (de) 2014-04-15 2018-03-15 Sanoxsys Gmbh Mittel zur Prävention und Therapie von Tumorerkrankungen
MX384605B (es) 2015-04-29 2025-03-14 Radius Pharmaceuticals Inc Combinación de palbociclib y rad1901 para usarse en el tratamiento de cáncer de mama en un sujeto con cáncer positivo a receptor de estrógeno.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714013D0 (en) * 1987-06-16 1987-07-22 Ici Plc (substituted-aralkyl)heterocyclic compounds
AR034142A1 (es) * 2000-09-08 2004-02-04 Sloan Kettering Inst Cancer Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
GB0129457D0 (en) * 2001-12-10 2002-01-30 Astrazeneca Ab Method of treatment

Also Published As

Publication number Publication date
US20050165081A1 (en) 2005-07-28
CA2468965C (en) 2011-08-30
AU2002347371A1 (en) 2003-07-09
NO20042912L (no) 2004-08-25
WO2003053438A1 (en) 2003-07-03
IL162150A0 (en) 2005-11-20
CN100408036C (zh) 2008-08-06
CY1108462T1 (el) 2014-04-09
CO5590926A2 (es) 2005-12-30
EP1997492A1 (de) 2008-12-03
PL369411A1 (en) 2005-04-18
ZA200404260B (en) 2005-10-26
JP2011016828A (ja) 2011-01-27
DE60228616D1 (de) 2008-10-09
NZ533106A (en) 2008-02-29
ES2303811T3 (es) 2009-02-01
HK1069335A1 (en) 2005-05-20
HUP0402023A3 (en) 2008-08-28
EP1455781A1 (de) 2004-09-15
ATE406160T1 (de) 2008-09-15
DK1455781T3 (da) 2008-11-24
RU2320339C2 (ru) 2008-03-27
AU2002347371B2 (en) 2007-05-10
KR20040066886A (ko) 2004-07-27
PT1455781E (pt) 2008-11-03
KR100858946B1 (ko) 2008-09-17
RU2004121162A (ru) 2005-05-20
EP1455781B1 (de) 2008-08-27
CA2468965A1 (en) 2003-07-03
JP2005516021A (ja) 2005-06-02
CN1630519A (zh) 2005-06-22
ES2303811T1 (es) 2008-09-01
BR0214798A (pt) 2004-10-19
JP5335173B2 (ja) 2013-11-06
SI1455781T1 (sl) 2008-12-31
IS7300A (is) 2004-06-04
MXPA04005394A (es) 2005-04-19
HUP0402023A2 (hu) 2005-01-28
GB0129457D0 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
RU2737496C2 (ru) Способы лечения рака
JP2011016828A (ja) 早期乳癌を有する閉経後の女性の処置のためのアナストロゾールの使用
KR20020073566A (ko) 에스트로겐과 배합된 선택적인 에스트로겐 수용체 조절자
EP3638232B1 (de) Tinostamustin zur verwendung bei der behandlung von sarkomen
JP7827774B2 (ja) 月経困難症治療用組成物
TW200307553A (en) Treatment of post-menopausal complaints in breast cancer patients
KR20160101027A (ko) 제약 조합물
Lentz Endocrine therapy of endometrial cancer
AU2004281527A1 (en) Breast cancer treatment regimen
Chawla et al. Use of Centchroman (Saheli) in conservative management of Menorrhagia: Our experience
NZ292017A (en) Use of raloxifene to treat endometrial cancer
KR20250160081A (ko) 에스트로겐-의존성 질환 치료 또는 예방용 약학적 조성물
HK1069335B (en) Use of anastrozole for the treatment of post-menopausal women having early breast cancer
HK40066922A (en) Treatment of breast cancer using combination therapies comprising an atp competitive akt inhibitor, a cdk4/6 inhibitor, and fulvestrant
CN112334138A (zh) 晚期雌激素受体阳性乳腺癌的治疗